Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - AEOLUS PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - AEOLUS PHARMACEUTICALS, INC. | exh31_1.htm |
| EX-23.2 - EXHIBIT 23.2 - AEOLUS PHARMACEUTICALS, INC. | exh23_2.htm |
| EX-23.1 - EXHIBIT 23.1 - AEOLUS PHARMACEUTICALS, INC. | exh23_1.htm |
| EX-31.2 - EXHIBIT 31.2 - AEOLUS PHARMACEUTICALS, INC. | exh31_2.htm |
| EX-21.1 - EXHIBIT 21.1 - AEOLUS PHARMACEUTICALS, INC. | exh21_1.htm |
| EX-10.27 - EXHIBIT 10.27 - AEOLUS PHARMACEUTICALS, INC. | exh10_27.htm |
| 10-K - AEOLUS PHARMACEUTICALS, INC - AEOLUS PHARMACEUTICALS, INC. | aeolus10k.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
In connection with the Annual Report of Aeolus Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ended September 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, John L. McManus, Principal Executive Officer of the Company, and Russell Skibsted, Principal Financial and Accounting Officer of the Company, each certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by the Report.
|
Date: December 27, 2011
/s/ John L. McManus
John L. McManus
President and Chief Executive Officer
(Principal Executive Officer)
Date: December 27, 2011
/s/ Russell Skibsted
Russell Skibsted
Chief Financial Officer and Secretary
(Principal Financial and Accounting Officer)